scispace - formally typeset
N

Nazli Namazi

Researcher at Tehran University of Medical Sciences

Publications -  107
Citations -  1803

Nazli Namazi is an academic researcher from Tehran University of Medical Sciences. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 20, co-authored 88 publications receiving 1136 citations. Previous affiliations of Nazli Namazi include Mashhad University of Medical Sciences & Tabriz University of Medical Sciences.

Papers
More filters
Journal ArticleDOI

Dietary Inflammatory Index and its Association with the Risk of Cardiovascular Diseases, Metabolic Syndrome, and Mortality: A Systematic Review and Meta-Analysis.

TL;DR: A substantial association between the DII and the risk for CVD and all types of mortality is observed, however, further cohort studies in different populations are needed to clarify this association.
Journal ArticleDOI

Effects of black seed (Nigella sativa) on metabolic parameters in diabetes mellitus: a systematic review.

TL;DR: N. sativa can improve glycemic status and lipid profile in diabetes models, however, more clinical trials are necessary to clarify beneficial effects of N. sativas, its effective type and dosage for diabetes management and its complications.
Journal ArticleDOI

Nigella sativa oil affects glucose metabolism and lipid concentrations in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trial.

TL;DR: Comparison of the two groups indicated that fasting blood sugar, glycated hemoglobin, triglyceride and low density lipoprotein–cholesterol changed significantly in intervention group compared to the placebo group.
Journal ArticleDOI

Solid lipid nanoparticles carrying Eugenia caryophyllata essential oil: the novel nanoparticulate systems with broad-spectrum antimicrobial activity

TL;DR: Solid lipid nanoparticles containing Eugenia caryophyllata essential oil were prepared by high‐shear homogenization and ultrasound methods, and used to eradicate pathogens, highlighting the effectiveness of SLN formulations against human pathogens.